References:
1. Makary MA, Overton HN, Wang P. Overprescribing is major contributor to opioid crisis.BMJ. 2017;359:j4792.
2. Kolodny A, Courtwright DT, Hwang CS, et al. The prescription opioid and heroin crisis: a public health approach to an epidemic of addiction. Annu Rev Public Health. 2015;36:559-574.
3. Rummans TA, Burton MC, Dawson NL. How Good Intentions Contributed to Bad Outcomes: The Opioid Crisis. Mayo Clin Proc. 2018;93(3):344-350.
4. Opioid- and Stimulant-related Harms in Canada. Accessed August 30, 2021. https://health-infobase.canada.ca/substance-related-harms/opioids-stimulants/
5. Overdose deaths accelerating during COVID-19. Published December 21, 2020. Accessed August 30, 2021. https://www.cdc.gov/media/releases/2020/p1218-overdose-deaths-covid-19.html
6. Luo F, Li M, Florence C. State-Level Economic Costs of Opioid Use Disorder and Fatal Opioid Overdose - United States, 2017. MMWR Morb Mortal Wkly Rep. 2021;70(15):541-546.
7. France RD, Urban BJ, Keefe FJ. Long-term use of narcotic analgesics in chronic pain. Social Science & Medicine. 1984;19(12):1379-1382. doi:10.1016/0277-9536(84)90027-3
8. Taub A. Opioid analgesics in the treatment of chronic intractable pain of non-neoplastic origin.Pain. 1984;18:S204.
9. Meldrum M. Opioids’ Long Shadow. AMA J Ethics. 2020;22(1):E729-E734.
10. Portenoy RK, Foley KM. Chronic use of opioid analgesics in non-malignant pain: report of 38 cases. Pain. 1986;25(2):171-186.
11. Dowell D, Haegerich TM, Chou R. CDC Guideline for Prescribing Opioids for Chronic Pain - United States, 2016. MMWR Recomm Rep. 2016;65(1):1-49.
12. Busse JW, Craigie S, Juurlink DN, et al. Guideline for opioid therapy and chronic noncancer pain. CMAJ. 2017;189(18):E659-E666.
13. Leydesdorff L, Milojević S. Scientometrics. arXiv [csDL]. Published online August 22, 2012. http://arxiv.org/abs/1208.4566
14. Birkle C, Pendlebury DA, Schnell J, Adams J. Web of Science as a data source for research on scientific and scholarly activity. Quantitative Science Studies. 2020;1(1):363-376.
15. Wilson V. Research methods: Content analysis. Evid Based Libr Inf Pract. 2016;11(1(S)):41.
16. Leung PTM, Macdonald EM, Stanbrook MB, Dhalla IA, Juurlink DN. A 1980 Letter on the Risk of Opioid Addiction. N Engl J Med. 2017;376(22):2194-2195.
17. Sud A, Zlahtic E, Cheng D, Moinnedin R, Upshur R. Time series-based bibliometric analysis of a systematic review of multidisciplinary care for opioid dose reduction: exploring the origins of the North American opioid crisis.Scientometrics.
18. Chow GC. Tests of Equality Between Sets of Coefficients in Two Linear Regressions.Econometrica. 1960;28(3):591-605.
19. Wagner AK, Soumerai SB, Zhang F, Ross-Degnan D. Segmented regression analysis of interrupted time series studies in medication use research. J Clin Pharm Ther. 2002;27(4):299-309.
20. Attal N, Chen YL, Kayser V, Guilbaud G. Behavioural evidence that systemic morphine may modulate a phasic pain-related behaviour in a rat model of peripheral mononeuropathy. Pain. 1991;47(1):65-70.
21. Brena SF, Sanders SH. Opioids in nonmalignant pain: questions in search of answers. Clin J Pain. 1991;7(4):342-345; discussion 346-349.
22. Dubner R. A call for more science, not more rhetoric, regarding opioids and neuropathic pain.Pain. 1991;47(1):1-2.
23. Jazat F, Guilbaud G. The “tonic” pain-related behaviour seen in mononeuropathic rats is modulated by morphine and naloxone. Pain. 1991;44(1):97-102.
24. Kupers RC, Konings H, Adriaensen H, Gybels JM. Morphine differentially affects the sensory and affective pain ratings in neurogenic and idiopathic forms of pain.Pain. 1991;47(1):5-12.
25. Yamamoto T, Yaksh TL. Spinal pharmacology of thermal hyperesthesia induced by incomplete ligation of sciatic nerve. I. Opioid and nonopioid receptors.Anesthesiology. 1991;75(5):817-826.
26. Baron R. Neuropathic pain. The long path from mechanisms to mechanism-based treatment.Anaesthesist. 2000;49(5):373-386.
27. Covington EC. Opiophobia, opiophilia, opioagnosia. Pain Med. 2000;1(3):217-223.
28. Fairbanks CA, Oanh Nguyen H, Grocholski BM, Wilcox GL. Moxonidine, a Selective Imidazoline–α2-Adrenergic Receptor Agonist, Produces Spinal Synergistic Antihyperalgesia with Morphine in Nerve-injured Mice.Anesthesiology. 2000;93(3):765-773. doi:10.1097/00000542-200009000-00026
29. Mindach M. No addiction in pain patients? Questions of a reading physician. Schmerz. 2000;14(3):186-191.
30. Quang-Cantagrel ND, Wallace MS, Magnuson SK. Opioid Substitution to Improve the Effectiveness of Chronic Noncancer Pain Control: A Chart Review.Anesthesia & Analgesia. 2000;90(4):933.
31. Taylor WF, Finkel AG, Robertson KR, et al. Methadone in the treatment of chronic nonmalignant pain: a 2-year follow-up. Pain Med. 2000;1(3):254-259.
32. Watson CP. The treatment of neuropathic pain: antidepressants and opioids. Clin J Pain. 2000;16(2 Suppl):S49-S55.
33. Bailey JA, Hurley RW, Gold MS. Crossroads of pain and addiction. Pain Med. 2010;11(12):1803-1818.
34. Jay GW. Opioid Medications and Correct Medical Usage. In: Clinician’s Guide to Chronic Headache and Facial Pain. CRC Press; 2010:235-258.
35. Kidner CL, Gatchel RJ, Mayer TG. MMPI disability profile is associated with degree of opioid use in chronic work-related musculoskeletal disorders. Clin J Pain. 2010;26(1):9-15.
36. Koeppe J, Armon C, Lyda K, Nielsen C, Johnson S. Ongoing pain despite aggressive opioid pain management among persons with HIV. Clin J Pain. 2010;26(3):190-198.
37. Laxmaiah Manchikanti M, Bert Fellows M, Hary Ailinani M. Therapeutic use, abuse, and nonmedical use of opioids: a ten-year perspective. Pain Physician. 2010;13:401-435.
38. Rhodin A, Stridsberg M, Gordh T. Opioid endocrinopathy: a clinical problem in patients with chronic pain and long-term oral opioid treatment. Clin J Pain. 2010;26(5):374-380.
39. Slater M-E, De Lima J, Campbell K, Lane L, Collins J. Opioids for the management of severe chronic nonmalignant pain in children: a retrospective 1-year practice survey in a children’s hospital. Pain Med. 2010;11(2):207-214.
40. Sullivan MD, Von Korff M, Banta-Green C, Merrill JO, Saunders K. Problems and concerns of patients receiving chronic opioid therapy for chronic non-cancer pain.Pain. 2010;149(2):345-353.
41. Geels FW, Pieters T, Snelders S. Cultural Enthusiasm, Resistance and the Societal Embedding of New Technologies: Psychotropic Drugs in the 20th Century.Technology Analysis & Strategic Management. 2007;19(2):145-165.
42. Van Zee A. The promotion and marketing of oxycontin: commercial triumph, public health tragedy.Am J Public Health. 2009;99(2):221-227.
43. Bernard SA, Chelminski PR, Ives TJ, Ranapurwala SI. Management of Pain in the United States-A Brief History and Implications for the Opioid Epidemic. Health Serv Insights. 2018;11:1178632918819440.
44. Webster F, Rice K, Sud A. A critical content analysis of media reporting on opioids: The social construction of an epidemic. Soc Sci Med. 2020;244:112642.
45. Timmermans S, Berg M, Berg PAM. The Gold Standard: The Challenge of Evidence-Based Medicine and Standardization in Health Care. Temple University Press; 2003.
46. Busse JW, Juurlink D, Guyatt GH. Addressing the limitations of the CDC guideline for prescribing opioids for chronic noncancer pain. CMAJ. 2016;188(17-18):1210-1211.
47. Dowell D, Haegerich T, Chou R. No Shortcuts to Safer Opioid Prescribing. N Engl J Med. 2019;380(24):2285-2287.
48. Kroenke K, Alford DP, Argoff C, et al. Challenges with Implementing the Centers for Disease Control and Prevention Opioid Guideline: A Consensus Panel Report.Pain Med. 2019;20(4):724-735.
49. Pawson R, Greenhalgh T, Harvey G, Walshe K. Realist review–a new method of systematic review designed for complex policy interventions. J Health Serv Res Policy. 2005;10 Suppl 1:21-34.
50. Upshur REG. Do clinical guidelines still make sense? No. Ann Fam Med. 2014;12(3):202-203.
51. Sud A, Buchman D, Furlan A, Selby P, Spithoff S, Upshur R. Chronic Pain and Opioid Prescribing: Three Ways for Navigating Complexity at the Clinical-Population Health Interface. Am J Public Health.
52. Process for updating the opioid prescribing guideline. Published November 3, 2021. Accessed December 24, 2021. https://www.cdc.gov/opioids/guideline-update/index.html
53. Stahl NA, Brozo WG, Simpson ML. Developing college vocabulary: A content analysis of instructional materials. Reading Research and Instruction. 1987;26(3):203-221. doi:10.1080/19388078709557910
54. Thelwall M. Are classic references cited first? An analysis of citation order within article sections. Scientometrics. 2019;120(2):723-731.
​​